Search Results | Pediatrics | American Academy of Pediatrics

1-17 of 17

Sort by

Sort Order Select

Journal Articles

A Method for Interdicting the Development of Severe Jaundice in Newborns by Inhibiting the Production of Bilirubin

Attallah Kappas, MD

Pediatrics (2004) 113 (1): 119–123.

Published: January 2004

View article

Journal Articles

Sn-Mesoporphyrin Interdiction of Severe Hyperbilirubinemia in Jehovah’s Witness Newborns as an Alternative to Exchange Transfusion

Attallah Kappas, MD, George S. Drummond, PhD, David P. Munson, MD, James R. Marshall, DO

Pediatrics (2001) 108 (6): 1374–1377.

Published: December 2001

View article

Journal Articles

A Single Dose of Sn-Mesoporphyrin Prevents Development of Severe Hyperbilirubinemia in Glucose-6-Phosphate Dehydrogenase-Deficient Newborns

Attallah Kappas, MD, George S. Drummond, PhD, Timos Valaes, MD

Pediatrics (2001) 108 (1): 25–30.

Published: July 2001

View article

Journal Articles

Crigler-Najjar Syndrome, 1952–2000: Learning From Parents and Patients About a Very Rare Disease and Using the Internet to Recruit Patients for Studies

Jerold F. Lucey, MD, Gautham K. Suresh, MD, Attallah Kappas, MD

Pediatrics (2000) 105 (5): 1152–1154.

Published: May 2000

View article

Journal Articles

Control of Severe Hyperbilirubinemia in Full-term Newborns With the Inhibitor of Bilirubin Production Sn-Mesoporphyrin

Jorge C. Martinez, MD, Horacio O. Garcia, MD, Lydia E. Otheguy, MD, George S. Drummond, PhD, Attallah Kappas, MD

Pediatrics (1999) 103 (1): 1–5.

Published: January 1999

View article

Journal Articles

Control of Hyperbilirubinemia in Glucose-6-Phosphate Dehydrogenase-deficient Newborns Using an Inhibitor of Bilirubin Production, Sn-Mesoporphyrin

Timos Valaes, MD, George S. Drummond, PhD, Attallah Kappas, MD

Pediatrics (1998) 101 (5): e1.

Published: May 1998

View article

Journal Articles

Direct Comparison of Sn-Mesoporphyrin, An Inhibitor of Bilirubin Production, and Phototherapy in Controlling Hyperbilirubinemia in Term and Near-Term Newborns

Attallah Kappas, George S. Drummond, Claudia Henschke, Timos Valaes

Pediatrics (1995) 95 (4): 468–474.

Published: April 1995

View article

Journal Articles

Control of Jaundice in Preterm Newborns by an Inhibitor of Bilirubin Production: Studies With Tin-Mesoporphyrin

Timos Valaes, Sophia Petmezaki, Claudia Henschke, George S. Drummond, Attallah Kappas

Pediatrics (1994) 93 (1): 1–11.

Published: January 1994

View article

Journal Articles

More to Be Learned From Crigler-Najjar Patients

RICHARD A. GALBRAITH, GEORGE S. DRUMMOND, ATTALLAH KAPPAS

Pediatrics (1993) 92 (1): 184–185.

Published: July 1993

View article

Journal Articles

Prolonged Clinical Use of a Heme Oxygenase Inhibitor: Hematological Evidence for an Inducible but Reversible Iron-Deficiency State

Attallah Kappas, George S. Drummond, Richard A. Galbraith

Pediatrics (1993) 91 (3): 537–539.

Published: March 1993

View article

Journal Articles

More to be Learned from Crigler-Najjar Patients

RICHARD A. GALBRAITH, GEORGE S. DRUMMOND, ATTALLAH KAPPAS

Pediatrics (1992) 89 (6): 1269.

Published: June 1992

View article

Journal Articles

Suppression of Bilirubin Production in the Crigler-Najjar Type I Syndrome: Studies with the Heme Oxygenase Inhibitor Tin-Mesoporphyrin

Richard A. Galbraith, George S. Drummond, Attallah Kappas

Pediatrics (1992) 89 (2): 175–182.

Published: February 1992

View article

Journal Articles

Succinylacetone and δ-Aminolevulinic Acid Dehydratase in Hereditary Tyrosinemia: Immunochemical Study of the Enzyme

Shigeru Sassa, Hiroyoshi Fujita, Attallah Kappas

Pediatrics (1990) 86 (1): 84–86.

Published: July 1990

View article

Journal Articles

Targeting of Heme Oxygenase Inhibitors to the Spleen Markedly Increases Their Ability to Diminish Bilirubin Production

Stephen A. Landaw, George S. Drummond, Attallah Kappas

Pediatrics (1989) 84 (6): 1091–1096.

Published: December 1989

View article

Journal Articles

Sn-Protoporphyrin Use in the Management of Hyperbilirubinemia in Term Newborns With Direct Coombs-Positive ABO Incompatibility

Attallah Kappas, George S. Drummond, Thomais Manola, Sophia Petmezaki, Timos Valaes

Pediatrics (1988) 81 (4): 485–497.

Published: April 1988

View article

Journal Articles

Photophysical Properties of Sn-Porphyrins: Potential Clinical Implications

John K. Delaney, David Mauzerall, George S. Drummond, Attallah Kappas

Pediatrics (1988) 81 (4): 498–504.

Published: April 1988

View article

Journal Articles

Enzymatic Defect in a Child With Hereditary Hepatic Porphyria Due to Homozygous δ-Aminolevulinic Acid Dehydratase Deficiency: Immunochemical Studies

Hiroyoshi Fujita, Shigeru Sassa, Johan Lundgren, Lars Holmberg, Stig Thunell ...

Pediatrics (1987) 80 (6): 880–885.

Published: December 1987

View article

NARROW

A Method for Interdicting the Development of Severe Jaundice in Newborns by Inhibiting the Production of Bilirubin

Sn-Mesoporphyrin Interdiction of Severe Hyperbilirubinemia in Jehovah’s Witness Newborns as an Alternative to Exchange Transfusion

A Single Dose of Sn-Mesoporphyrin Prevents Development of Severe Hyperbilirubinemia in Glucose-6-Phosphate Dehydrogenase-Deficient Newborns

Crigler-Najjar Syndrome, 1952–2000: Learning From Parents and Patients About a Very Rare Disease and Using the Internet to Recruit Patients for Studies

Control of Severe Hyperbilirubinemia in Full-term Newborns With the Inhibitor of Bilirubin Production Sn-Mesoporphyrin

Control of Hyperbilirubinemia in Glucose-6-Phosphate Dehydrogenase-deficient Newborns Using an Inhibitor of Bilirubin Production, Sn-Mesoporphyrin

Direct Comparison of Sn-Mesoporphyrin, An Inhibitor of Bilirubin Production, and Phototherapy in Controlling Hyperbilirubinemia in Term and Near-Term Newborns

Control of Jaundice in Preterm Newborns by an Inhibitor of Bilirubin Production: Studies With Tin-Mesoporphyrin

More to Be Learned From Crigler-Najjar Patients

Prolonged Clinical Use of a Heme Oxygenase Inhibitor: Hematological Evidence for an Inducible but Reversible Iron-Deficiency State

More to be Learned from Crigler-Najjar Patients

Suppression of Bilirubin Production in the Crigler-Najjar Type I Syndrome: Studies with the Heme Oxygenase Inhibitor Tin-Mesoporphyrin

Succinylacetone and δ-Aminolevulinic Acid Dehydratase in Hereditary Tyrosinemia: Immunochemical Study of the Enzyme

Targeting of Heme Oxygenase Inhibitors to the Spleen Markedly Increases Their Ability to Diminish Bilirubin Production

Sn-Protoporphyrin Use in the Management of Hyperbilirubinemia in Term Newborns With Direct Coombs-Positive ABO Incompatibility

Photophysical Properties of Sn-Porphyrins: Potential Clinical Implications

Enzymatic Defect in a Child With Hereditary Hepatic Porphyria Due to Homozygous δ-Aminolevulinic Acid Dehydratase Deficiency: Immunochemical Studies

Email alerts

Journals

Policy

Books

News

Solutions

Institutions/Librarians

Group Practices

Licensing/Permissions

Integrations

Advertising

Email alerts

Journals

News

Solutions

This Feature Is Available To Subscribers Only